Real-world clinical experience with Obsidio Conformable Embolic
Initial clinical experience demonstrated successful embolization of end-organ bleeds and hypervascular tumors utilizing Obsidio, thus making it an effective embolic agent alone or in conjunction with other embolic devices.
Authors
- Nariman Nezami (ORCID: https://orcid.org/0000-0002-8829-1548)
- John Karageorgiou (ORCID: https://orcid.org/0000-0002-4966-1139)
- Joshua P. Jones (ORCID: https://orcid.org/0000-0002-3518-2639)
- Mikin Patel (ORCID: https://orcid.org/0000-0001-7860-2966)
- Osman Ahmed (ORCID: https://orcid.org/0000-0003-2440-2437)
- Abhishek Kumar (ORCID: https://orcid.org/0000-0003-0134-2857)
Institutions
- Rutgers, The State University of New Jersey (US)
- Georgetown University (US)
- MedStar Georgetown University Hospital (US)
- Boston Scientific (United States) (US)
- University of Chicago Medical Center (US)
- Mallinckrodt (United States) (US)
- Vince Lombardi Cancer Clinic (US)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- CVIR Endovascular
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1186/s42155-025-00555-w
- Citations
- 3
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 4.06
Funders
- Boston Scientific Corporation